World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
99
Citations
47733
World Ranking
427
National Ranking
197

Medicine

D-Index
99
Citations
48361
World Ranking
8445
National Ranking
4366

Lloyd Mayer publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Lloyd Mayer sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 390 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Lloyd Mayer D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Lloyd Mayer sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 99 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Lloyd Mayer was affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focused on medical and immunological fields, with a significant number of publications contributing to the study of immune responses, allergy, and gastrointestinal diseases.

The main field of study for Mayer was medicine, with 13 publications recorded. Within this broad domain, significant subfields included:

  • Immunology and Allergy
  • Immunology
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Epidemiology

Their work touched on several main topics such as:

  • Food Allergy and Anaphylaxis Research
  • Cell Adhesion Molecules Research
  • Immunotherapy and Immune Responses
  • Monoclonal and Polyclonal Antibodies Research
  • Diverticular Disease and Complications
  • Biliary and Gastrointestinal Fistulas
  • Anorectal Disease Treatments and Outcomes

Lloyd Mayer published multiple papers, some noteworthy recent publications include:

  • A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn's Disease (2022, Gastroenterology)
  • Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial (2021, UNC Libraries)
  • The natural history of milk allergy in an observational cohort (2020, UNC Libraries)
  • Enteroendocrine cells express functional Toll-like receptors (2020, UNC Libraries)
  • A Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis (2021, UNC Libraries)

The venues where Mayer frequently published were:

  • UNC Libraries (6 publications)
  • Gastroenterology (1 publication)

Mayer collaborated often with several researchers, frequently coauthoring with:

  • William J. Sandborn
  • Stephen B. Hanauer
  • Robert A. Wood
  • Scott H. Sicherer
  • Brian P. Vickery

Best Publications

  • Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    Stephen B Hanauer;Brian G Feagan;Gary R Lichtenstein;Lloyd F Mayer

  • A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

    S. R. Targan;S. B. Hanauer;S. J. H. Van Deventer;L. Mayer

  • Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

    Beth Levine;Jill Kalman;Lloyd Mayer;Howard M. Fillit

  • Infliximab for the treatment of fistulas in patients with Crohn's disease.

    D.H. Present;P.J. Rutgeerts;S.R. Targan;S.B. Hanauer

  • Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

    Paul Rutgeerts;G D'Haens;S Targan;E Vasiliauskas

  • Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

    Paul Rutgeerts;Brian G. Feagan;Gary R. Lichtenstein;Lloyd F. Mayer

  • Anti-interleukin-12 antibody for active Crohn's disease

    Peter J. Mannon;Ivan J. Fuss;Lloyd Mayer;Charles O. Elson

  • Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

    Stephen B Hanauer;Carrie L Wagner;Mohan Bala;Lloyd Mayer

  • Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance

    Bo Huang;Jie Zhao;Hongxing Li;Kai-Li He

  • Evidence for function of Ia molecules on gut epithelial cells in man.

    Lloyd Mayer;Robert Shlien

  • The incidence and management of infusion reactions to infliximab: a large center experience

    Adam Cheifetz;Michelle Smedley;Sara Martin;Monica Reiter

  • Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals

    Meimei Shan;Maurizio Gentile;John R. Yeiser;A. Cooper Walland

  • Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

    Bruce E. Sands;William J. Tremaine;William J. Sandborn;Paul J. Rutgeerts

  • Oral tolerance and its relation to food hypersensitivities.

    Mirna Chehade;Lloyd Mayer

  • The natural history of egg allergy in an observational cohort.

    Robert A. Wood;Scott H. Sicherer;Brian P. Vickery;Stacie M. Jones

  • Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial

    William J Sandborn;Daniel H Present;Kim L Isaacs;Douglas C Wolf

  • Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases

    Zaruhi Hovhannisyan;Jacquelyn Treatman;Dan R. Littman;Lloyd Mayer

  • Antigen processing and presentation by intestinal epithelial cells – polarity and complexity

    Robert M Hershberg;Lloyd F Mayer

  • Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut

    Natalia Shulzhenko;Andrey Morgun;Andrey Morgun;William Hsiao;Michele Battle

  • Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.

    James F. Marion;Jerome D. Waye;Daniel H. Present;Yuriy Israel

Frequent Co-Authors

Maria T. Abreu
Maria T. Abreu University of Miami
Stephen B. Hanauer
Stephen B. Hanauer Northwestern University
Jay C. Unkeless
Jay C. Unkeless Icahn School of Medicine at Mount Sinai
Huabao Xiong
Huabao Xiong Icahn School of Medicine at Mount Sinai
Matthieu Allez
Matthieu Allez Université Paris Cité
Charlotte Cunningham-Rundles
Charlotte Cunningham-Rundles Icahn School of Medicine at Mount Sinai
William J. Sandborn
William J. Sandborn University of California, San Diego
Hugh A. Sampson
Hugh A. Sampson Icahn School of Medicine at Mount Sinai
Stephan R. Targan
Stephan R. Targan Cedars-Sinai Medical Center
M. Cecilia Berin
M. Cecilia Berin Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in pursuing a career in microbiology or related healthcare fields, several online healthcare degrees that pay well offer excellent opportunities. These programs provide flexible paths for students to enter high-demand sectors such as medical research, clinical laboratory science, and healthcare administration.

Public health is another complementary area to microbiology. Many students consider enrolling in online public health masters programs easy to get into, which can enhance understanding of disease prevention, epidemiology, and community health. These degrees typically open doors to impactful careers in health policy and management.

A specialized but rewarding career option is becoming a child life specialist. This role focuses on supporting children through medical treatment emotionally and psychologically. Learning about the child life specialists salary helps prospective students gauge the financial benefits of this profession.

Accessibility is another important consideration for many students. There are also valuable degrees for felons that enable individuals with records to pursue reputable education and successful career pathways, particularly in healthcare and the sciences.

Best Scientists Citing Lloyd Mayer

Recently Published Articles